Oncolytics Biotech Inc. Stock Toronto S.E.
Equities
CA6823101077
Biotechnology & Medical Research
Sales 2024 * | 750K 546K | Sales 2025 * | 5.72M 4.17M | Capitalization | 116M 84.57M |
---|---|---|---|---|---|
Net income 2024 * | -35M -25.48M | Net income 2025 * | -40M -29.12M | EV / Sales 2024 * | 155 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 20.3 x |
P/E ratio 2024 * |
-3.51
x | P/E ratio 2025 * |
-3.57
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.1% |
Latest transcript on Oncolytics Biotech Inc.
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |